BACKGROUND: Tumorigenicity is an associated risk for transplantation of hepatocytes differentiated from human induced pluripotent stem (hiPS) cells. Hepatocytes express the enzymes galactokinase and ornithine transcarbamylase (OTC) to aid in their own survival. However, hiPS cells do not express these enzymes, and therefore, are not be expected to survive in a medium containing galactose and ornithine and lacking glucose and arginine. MATERIALS AND METHODS: Real-time quantitative polymerase chain reaction (PCR) was performed to analyze the expression of galactokinase 1 (GALK1)1 and GALK2, ornithine carbamyltransferase, and phenylalanine hydroxylase (PAH). The hiPS cell line 201B7 was cultured in hepatocyte selection medium (HSM), which lack...
Human induced pluripotent stem (iPS) cells hold great promise for advancements in developmental biol...
The potential use of stem/progenitor cells as alternative cell sources to mature hepatocytes for liv...
Hepatocyte-like cells (HLCs) generated from various human pluripotent stem cells (hPSCs), mostly ind...
Tumorigenicity is an associated risk for transplantation of hepatocytes differentiated from human in...
Hepatocyte differentiation inducer (HDI) lacks both glucose and arginine, but is supplemented with g...
Orthotopic liver transplantation remains the only curative treatment for liver disease. However, the...
There is a strong anticipated future for human induced pluripotent stem cell-derived hepatocytes (hi...
Human pluripotent stem cells (hPSCs) can self-renew indefinitely in vitro while maintaining the capa...
Background: Generating hepatocytes with complete liver functions is still a challenge and developing...
Hepatocyte transplantation has been used to treat liver disease. The availability of cells for thes...
Orthotopic liver transplantation is the gold standard treatment for end stage liver disease or inbor...
Chronic liver diseases represent a primary worldwide health concern. Liver transplantation is the on...
AbstractMaturation of induced pluripotent stem cells (hiPSCs) to hepatocyte-like cells (HLCs) has be...
Accurate prediction of human drug toxicity is a vital part of the drug discovery process. However, t...
Background/Aims: Hepatocyte-like cells derived from human pluripotent stem cells could be an importa...
Human induced pluripotent stem (iPS) cells hold great promise for advancements in developmental biol...
The potential use of stem/progenitor cells as alternative cell sources to mature hepatocytes for liv...
Hepatocyte-like cells (HLCs) generated from various human pluripotent stem cells (hPSCs), mostly ind...
Tumorigenicity is an associated risk for transplantation of hepatocytes differentiated from human in...
Hepatocyte differentiation inducer (HDI) lacks both glucose and arginine, but is supplemented with g...
Orthotopic liver transplantation remains the only curative treatment for liver disease. However, the...
There is a strong anticipated future for human induced pluripotent stem cell-derived hepatocytes (hi...
Human pluripotent stem cells (hPSCs) can self-renew indefinitely in vitro while maintaining the capa...
Background: Generating hepatocytes with complete liver functions is still a challenge and developing...
Hepatocyte transplantation has been used to treat liver disease. The availability of cells for thes...
Orthotopic liver transplantation is the gold standard treatment for end stage liver disease or inbor...
Chronic liver diseases represent a primary worldwide health concern. Liver transplantation is the on...
AbstractMaturation of induced pluripotent stem cells (hiPSCs) to hepatocyte-like cells (HLCs) has be...
Accurate prediction of human drug toxicity is a vital part of the drug discovery process. However, t...
Background/Aims: Hepatocyte-like cells derived from human pluripotent stem cells could be an importa...
Human induced pluripotent stem (iPS) cells hold great promise for advancements in developmental biol...
The potential use of stem/progenitor cells as alternative cell sources to mature hepatocytes for liv...
Hepatocyte-like cells (HLCs) generated from various human pluripotent stem cells (hPSCs), mostly ind...